Volume 29, Issue 4, Pages (October 2008)

Slides:



Advertisements
Similar presentations
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Advertisements

Sustained Interactions between T Cell Receptors and Antigens Promote the Differentiation of CD4+ Memory T Cells  Chulwoo Kim, Theodore Wilson, Kael F.
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Following the Development of a CD4 T Cell Response In Vivo
Initial T Cell Receptor Transgenic Cell Precursor Frequency Dictates Critical Aspects of the CD8+ T Cell Response to Infection  Vladimir P. Badovinac,
Volume 27, Issue 4, Pages (October 2007)
Hans-Peter Raué, Carol Beadling, Jennifer Haun, Mark K. Slifka 
Volume 45, Issue 1, Pages (July 2016)
Volume 13, Issue 6, Pages (November 2015)
Volume 33, Issue 1, Pages (July 2010)
Volume 31, Issue 5, Pages (November 2009)
Volume 45, Issue 2, Pages (August 2016)
Volume 28, Issue 5, Pages (May 2008)
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 2, Pages (February 2008)
Lung Airway-Surveilling CXCR3hi Memory CD8+ T Cells Are Critical for Protection against Influenza A Virus  Bram Slütter, Lecia L. Pewe, Susan M. Kaech,
Volume 11, Issue 6, Pages (June 2012)
NKT Cells Inhibit the Onset of Diabetes by Impairing the Development of Pathogenic T Cells Specific for Pancreatic β Cells  Lucie Beaudoin, Véronique.
Volume 31, Issue 1, Pages (July 2009)
Volume 25, Issue 3, Pages (September 2006)
Protective Capacity of Memory CD8+ T Cells Is Dictated by Antigen Exposure History and Nature of the Infection  Jeffrey C. Nolz, John T. Harty  Immunity 
Volume 21, Issue 3, Pages (September 2004)
Volume 33, Issue 1, Pages (July 2010)
Volume 37, Issue 5, Pages (November 2012)
Volume 45, Issue 1, Pages (July 2016)
Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation 
A Two-Step Process for Thymic Regulatory T Cell Development
Volume 31, Issue 5, Pages (November 2009)
Volume 29, Issue 1, Pages (July 2008)
In Situ Activation and Expansion of Host Tregs: A New Approach to Enhance Donor Chimerism and Stable Engraftment in Major Histocompatibility Complex-Matched.
Volume 29, Issue 2, Pages (August 2008)
Dynamics of Blood-Borne CD8 Memory T Cell Migration In Vivo
Ravindra Majeti, Christopher Y. Park, Irving L. Weissman 
Volume 29, Issue 6, Pages (December 2008)
Volume 28, Issue 5, Pages (May 2008)
Volume 13, Issue 2, Pages (February 2006)
Blimp-1 Transcription Factor Is Required for the Differentiation of Effector CD8+ T Cells and Memory Responses  Axel Kallies, Annie Xin, Gabrielle T.
Francis Coffey, Boris Alabyev, Tim Manser  Immunity 
Volume 32, Issue 5, Pages (May 2010)
Volume 38, Issue 6, Pages (June 2013)
Volume 33, Issue 3, Pages (September 2010)
An Interleukin-21- Interleukin-10-STAT3 Pathway Is Critical for Functional Maturation of Memory CD8+ T Cells  Weiguo Cui, Ying Liu, Jason S. Weinstein,
Volume 38, Issue 3, Pages (March 2013)
Volume 35, Issue 4, Pages (October 2011)
Volume 32, Issue 1, Pages (January 2010)
Opposing Effects of TGF-β and IL-15 Cytokines Control the Number of Short-Lived Effector CD8+ T Cells  Shomyseh Sanjabi, Munir M. Mosaheb, Richard A.
Volume 43, Issue 5, Pages (November 2015)
Volume 39, Issue 1, Pages (July 2013)
Volume 41, Issue 1, Pages (July 2014)
T Cells with Low Avidity for a Tissue-Restricted Antigen Routinely Evade Central and Peripheral Tolerance and Cause Autoimmunity  Dietmar Zehn, Michael.
Matthew A. Williams, Eugene V. Ravkov, Michael J. Bevan  Immunity 
Volume 27, Issue 2, Pages (August 2007)
Susan M. Kaech, Scott Hemby, Ellen Kersh, Rafi Ahmed  Cell 
Volume 32, Issue 1, Pages (January 2010)
SAP Protein-Dependent Natural Killer T-like Cells Regulate the Development of CD8+ T Cells with Innate Lymphocyte Characteristics  Mihalis Verykokakis,
Volume 30, Issue 4, Pages (April 2009)
Volume 28, Issue 5, Pages (May 2008)
Volume 40, Issue 2, Pages (February 2014)
Volume 38, Issue 6, Pages (June 2013)
Volume 38, Issue 2, Pages (February 2013)
Volume 31, Issue 5, Pages (November 2009)
Volume 35, Issue 4, Pages (October 2011)
Volume 13, Issue 6, Pages (November 2015)
Volume 25, Issue 4, Pages (April 2017)
Volume 25, Issue 1, Pages (July 2006)
Volume 31, Issue 2, Pages (August 2009)
Volume 23, Issue 4, Pages (October 2005)
Volume 39, Issue 5, Pages (November 2013)
Volume 25, Issue 4, Pages (October 2006)
Immunization with IR or F/T elicits activated OT-I cells of distinct phenotypes. Immunization with IR or F/T elicits activated OT-I cells of distinct phenotypes.
Presentation transcript:

Volume 29, Issue 4, Pages 650-659 (October 2008) Memory Inflation during Chronic Viral Infection Is Maintained by Continuous Production of Short-Lived, Functional T Cells  Christopher M. Snyder, Kathy S. Cho, Elizabeth L. Bonnett, Serani van Dommelen, Geoffrey R. Shellam, Ann B. Hill  Immunity  Volume 29, Issue 4, Pages 650-659 (October 2008) DOI: 10.1016/j.immuni.2008.07.017 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Inflationary T Cells Remain Functional throughout Chronic MCMV Infection (A) The percentage of MCMV-specific T cells with the indicated specificity were measured over time by MHC-tetramer staining. Each symbol represents an individual mouse. The black line represents the average of all mice in this experiment. Note that the scale is different for M45- and M57-specific T cell populations. The data are representative of > 20 experiments. (B) For assessment of the percentage of antigen-specific cells that can produce IFN-γ, peripheral blood from individual mice infected for > 3 months was divided and stained with the indicated tetramer or stimulated with the indicated peptide and assessed for IFN-γ production. Except for those of the naive, tetramer-staining control, the FACS plots shown in each column represent the same mouse. A summary of the data from multiple mice and two independent experiments is shown in the graphs to the right. The solid line in each graph represents an ideal 1:1 correlation between tetramer staining and IFN-γ production. (C) Peripheral-blood cells from chronically infected mice were stimulated as described above and stained for IFN-γ and TNF-α production. The data are representative of three independent experiments. (D) The survival of peptide-loaded targets was assessed 18 hr after injection into chronically infected mice (two mice per group, one experiment). Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 Phenotype of Stable and Inflationary CD8+ T Cells Peripheral blood and/or splenocytes from mice infected for > 3 months was stained with the indicated tetramer, as well as with antibodies specific for CD8 and the indicated cell-surface molecule. The plots shown are gated on tetramer+, CD8+ T cells (black line) or tetramer−, CD8+ T cells from the same sample (shaded histogram). Data are compiled from different sets of infected mice measured at different time points during chronic infection (at least 3 months after infection) and are representative of at least four individual mice per stain. CD43 stains are from a single experiment; all others are representative of at least three independent experiments. Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 Inflationary T Cells Fail to Divide in SCID Recipients but Can Respond to a New Viral Infection (A) Splenocytes from C57BL/6 mice infected for > 3 months were transferred into C57BL/6-SCID mice or naive CD45.1 congenic mice. Naive, CD45.1 congenic recipients were infected with MCMV 2 days later. Peripheral blood from SCID recipients (day 12 after transfer) or splenocytes from CD45.1 congenic recipients (day 7 after infection) were stained with the indicated tetramers. The FACS plots have been gated on CD8+ donor-derived T cells in all cases. Data are representative of two independent experiments. (B) For assessment of the ability of differentiated T cells to divide in response to antigen, CD8+-enriched splenocytes were FACS sorted for CD8+, CD27hi, and CD27lo cells. Sorted cells were CFSE labeled and transferred into naive, congenic mice. Recipients were infected 1 hr later, and donor-derived cells were analyzed in the peripheral blood on day 7 after transfer. Numbers represent the percentage of all CD8+ T cells that fall into the indicated gates in the shown FACS plots. Data are from a single experiment. Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 Inflationary T Cells Decline Over Time in both Immune and Naive Recipients Splenocytes from C57BL/6 mice infected for > 3 months were harvested and transferred into infection-matched, CD45.1 congenic recipients. Donor-derived tetramer+ T cells were tracked over time as a percentage of all CD8+ T cells in the peripheral blood of recipients. (A and B) Extensively proliferated populations of inflationary T cells (CFSE negative, on the basis of recipient cells) were measured over time. (A) FACS plots at two time points from the same individual mice gated on donor-derived CD8+ T cells. (B) Percentage of donor-derived tetramer+ stable (left panels) or inflationary (right panels) T cells that were CFSE− either 49 or 119 days after transfer in this experiment. The Student's t test was used for assessing significance. (C) Donor-derived MCMV-specific T cells were measured over time. When measured as a percentage of all CD8+ T cells, donor-derived CD8+ T cells engrafted ∼1.5 to 2 times better in naive recipients compared to immune recipients. As a correction for these differences in the “take” of the donor-derived population, the percentage of the donor-derived MCMV-specific T cells was normalized to 100% at the first time point. The error bars represent the standard deviation from the average. T cell half-life was estimated by the length of time it took for the population to be reduced by 50% in circulation, relative to all CD8+ T cells. (D) The total (donor + recipient) tetramer-staining population from the same mice as in (C) is shown. Error bars show the standard deviation. Data are representative of four independent experiments. Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 Recruitment of Naive T Cells Occurs during Chronic Infection C57BL/6 mice that were infected for > 3 months were treated with busulfan and injected with bone marrow from naive CD45.1 congenic donors. Donor-derived MCMV-specific T cells in the peripheral blood were tracked by intracellular cytokine staining over time. (A) Donor-derived MCMV-specific T cells were measured in the peripheral blood of recipients. Shown are representative FACS plots (from three independent experiments) gated on all CD8+ T cells from mice that received naive bone marrow 9 weeks earlier. (B) Data from all three independent experiments were combined. The graphs show peripheral-blood donor-derived cells that produced IFN-γ in response to the indicated peptides as a percentage of the total peptide-specific IFN-γ response. The data were normalized to the amount of donor-derived IFN-γ found at the first time point. The lines represent the average of the donor responses over time. (C) The data from (B) was replotted to show the correlation between the percentage of CD8+ T cells that were donor derived and the percentage of MCMV-specific T cells that were donor derived. (D) Chronically infected mice received CD3-depleted donor bone marrow after busulfan treatment. Shown are representative FACS plots from four individual mice in one experiment. Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 Naive T Cells Do Not Account for the Replacement of all Decaying, Circulating, Differentiated T Cells (A) The FACS plots show an individual mouse (from the experiments described in Figure 5) in which most of the newly produced T cells were donor derived but most MCMV-specific T cells were recipient derived, 10 months after transplant. (B) MCMV-specific chimerism (from the experiments in Figure 5) is shown for several mice with a high degree of chimerism within double-positive thymocytes. (C) Donor-derived MCMV-specific T cells were transferred at the peak of T cell expansion (day 7 after infection) and measured at 2 weeks and at 6–7 months after transfer. Sample FACS plots are from the same mice at each time point. The numbers indicate the percentage of all tetramer+ cells that are donor derived. Data are representative of two independent experiments. (D) FACS plots show two examples of dramatic inflation of the donor-derived MCMV-specific T cell populations 7 months after transfer. (E) Combined data (as in panels C and D) from multiple mice and two independent experiments. Shown is the donor-derived tetramer+ population as a percentage of all tetramer+ T cells to adjust for inflation of the m139- and M38-specific populations over time. Lines connect individual mice at either 2 wk after transfer (3 wk after infection) or 6–7 months after transfer. IE3-specific T cells were not measured at 2 wk after transfer. Immunity 2008 29, 650-659DOI: (10.1016/j.immuni.2008.07.017) Copyright © 2008 Elsevier Inc. Terms and Conditions